Scotiabank Maintains Sector Outperform on AbbVie, Raises Price Target to $320

Benzinga · 2d ago
Scotiabank analyst Louise Chen maintains AbbVie (NYSE:ABBV) with a Sector Outperform and raises the price target from $280 to $320.